Literature DB >> 26897135

Cell intrinsic and extrinsic regulation of leukemia cell metabolism.

Yajian Jiang1, Daisuke Nakada2.   

Abstract

Metabolic homeostasis is a fundamental property of cells that becomes dysregulated in cancer to meet the altered, often heightened, demand for metabolism for increased growth and proliferation. Oncogenic mutations can directly change cellular metabolism in a cell-intrinsic manner, priming cells for malignancy. Additionally, cell-extrinsic cues from the microenvironment, such as hypoxia, nutrient availability, oxidative stress, and crosstalk from surrounding cells can also affect cancer cell metabolism, and produce metabolic heterogeneity within the tumor. Here, we highlight recent findings revealing the complexity and adaptability of leukemia cells to coordinate metabolism.

Entities:  

Keywords:  AMPK; Cell intrinsic; Leukemia; Metabolism; Microenvironment

Mesh:

Year:  2016        PMID: 26897135      PMCID: PMC5949883          DOI: 10.1007/s12185-016-1958-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  129 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow.

Authors:  Yoshio Katayama; Michela Battista; Wei-Ming Kao; Andrés Hidalgo; Anna J Peired; Steven A Thomas; Paul S Frenette
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

Review 3.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

4.  Overweight as a prognostic factor in children with acute lymphoblastic leukemia.

Authors:  Cristina B Gelelete; Sandra H Pereira; Alice Maria B Azevedo; Leandro S Thiago; Mariana Mundim; Marcelo G P Land; Elaine S Costa
Journal:  Obesity (Silver Spring)       Date:  2011-06-30       Impact factor: 5.002

5.  Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.

Authors:  Nathalie Jacque; Anne Marie Ronchetti; Clément Larrue; Godelieve Meunier; Rudy Birsen; Lise Willems; Estelle Saland; Justine Decroocq; Thiago Trovati Maciel; Mireille Lambert; Laury Poulain; Marie Anne Hospital; Pierre Sujobert; Laure Joseph; Nicolas Chapuis; Catherine Lacombe; Ivan Cruz Moura; Susan Demo; Jean Emmanuel Sarry; Christian Recher; Patrick Mayeux; Jérôme Tamburini; Didier Bouscary
Journal:  Blood       Date:  2015-07-17       Impact factor: 22.113

6.  Metabolic signature identifies novel targets for drug resistance in multiple myeloma.

Authors:  Patricia Maiso; Daisy Huynh; Michele Moschetta; Antonio Sacco; Yosra Aljawai; Yuji Mishima; John M Asara; Aldo M Roccaro; Alec C Kimmelman; Irene M Ghobrial
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

7.  Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK).

Authors:  Kay Barnes; Jean C Ingram; Omar H Porras; L Felipe Barros; Emma R Hudson; Lee G D Fryer; Fabienne Foufelle; David Carling; D Grahame Hardie; Stephen A Baldwin
Journal:  J Cell Sci       Date:  2002-06-01       Impact factor: 5.285

8.  Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104.

Authors:  Juliana Benito; Yuexi Shi; Barbara Szymanska; Hernan Carol; Ingrid Boehm; Hongbo Lu; Sergej Konoplev; Wendy Fang; Patrick A Zweidler-McKay; Dario Campana; Gautam Borthakur; Carlos Bueso-Ramos; Elizabeth Shpall; Deborah A Thomas; Craig T Jordan; Hagop Kantarjian; William R Wilson; Richard Lock; Michael Andreeff; Marina Konopleva
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

9.  Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia.

Authors:  Daniel Herranz; Alberto Ambesi-Impiombato; Jessica Sudderth; Marta Sánchez-Martín; Laura Belver; Valeria Tosello; Luyao Xu; Agnieszka A Wendorff; Mireia Castillo; J Erika Haydu; Javier Márquez; José M Matés; Andrew L Kung; Stephen Rayport; Carlos Cordon-Cardo; Ralph J DeBerardinis; Adolfo A Ferrando
Journal:  Nat Med       Date:  2015-09-21       Impact factor: 53.440

10.  Leukemia Mediated Endothelial Cell Activation Modulates Leukemia Cell Susceptibility to Chemotherapy through a Positive Feedback Loop Mechanism.

Authors:  Bahareh Pezeshkian; Christopher Donnelly; Kelley Tamburo; Timothy Geddes; Gerard J Madlambayan
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more
  13 in total

Review 1.  Hematopoietic stem cell fate through metabolic control.

Authors:  Kyoko Ito; Keisuke Ito
Journal:  Exp Hematol       Date:  2018-05-25       Impact factor: 3.084

2.  Guest editorial: Cooperative networks for stem cell homeostasis in normal and malignant hematopoiesis: from metabolism to epigenetics.

Authors:  Atsushi Hirao
Journal:  Int J Hematol       Date:  2016-04-19       Impact factor: 2.490

3.  The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells.

Authors:  Xiyuan Lu; Lina Han; Jonathan Busquets; Meghan Collins; Alessia Lodi; Joseph R Marszalek; Marina Konopleva; Stefano Tiziani
Journal:  Front Oncol       Date:  2021-08-20       Impact factor: 5.738

4.  Autophagy-Dependent Generation of Free Fatty Acids Is Critical for Normal Neutrophil Differentiation.

Authors:  Thomas Riffelmacher; Alexander Clarke; Felix C Richter; Amanda Stranks; Sumeet Pandey; Sara Danielli; Philip Hublitz; Zhanru Yu; Errin Johnson; Tobias Schwerd; James McCullagh; Holm Uhlig; Sten Eirik W Jacobsen; Anna Katharina Simon
Journal:  Immunity       Date:  2017-09-12       Impact factor: 31.745

5.  AMPK promotes the survival of colorectal cancer stem cells.

Authors:  Bing Guo; Xin Han; Diane Tkach; Shu-Guang Huang; Dong Zhang
Journal:  Animal Model Exp Med       Date:  2018-07-28

Review 6.  mTOR Regulation of Metabolism in Hematologic Malignancies.

Authors:  Simone Mirabilii; Maria Rosaria Ricciardi; Agostino Tafuri
Journal:  Cells       Date:  2020-02-11       Impact factor: 6.600

7.  Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5'AMP-Activated Kinase Inactivation.

Authors:  Valeria Tosello; Deborah Bongiovanni; Ludovica Di Martino; Cinzia Franchin; Paola Zanovello; Giorgio Arrigoni; Erich Piovan
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

Review 8.  Transcriptional and Microenvironmental Regulation of Lineage Ambiguity in Leukemia.

Authors:  Tianyuan Hu; Rebecca Murdaugh; Daisuke Nakada
Journal:  Front Oncol       Date:  2017-11-06       Impact factor: 6.244

9.  Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia.

Authors:  Yajing Chu; Yangpeng Chen; Mengke Li; Deyang Shi; Bichen Wang; Yu Lian; Xuelian Cheng; Xiaomin Wang; Mingjiang Xu; Tao Cheng; Jun Shi; Weiping Yuan
Journal:  Cancer Sci       Date:  2019-05-29       Impact factor: 6.716

10.  Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin.

Authors:  Yogesh Rai; Priyanshu Yadav; Neeraj Kumari; Namita Kalra; Anant Narayan Bhatt
Journal:  Biosci Rep       Date:  2019-09-24       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.